Aug 09,2016

Senseonics Holdings, Inc. Reports Second Quarter 2016 Financial Results

enseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter and six months ended June 30, 2016. Net loss was $11.9 million, or $0.13 per share, in the second quarter of 2016, compared to $7.2 million, or $3.68 per share, in the second quarter of 2015.

View Analyst & Ambassador Comments
Go to original news
Aug 10,2016

Fit4D (now named Cecelia Health) Announces Expansion Plan To Have Largest Team Of Certified Diabetes Educators In The United States By AADE 2017

Fit4D (now named Cecelia Health), the New York based technology company with intelligent scripting algorithms that enables Certified Diabetes Educators (CDEs) to deliver personalized care at scale, announced today that they will have the largest team of CDEs in the United States by the 2017 annual AADE conference. The American Association of Diabetes Educators (AADE) Annual conference is the largest gathering of diabetes educators in the country.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 10,2016

CareSkore gets $4.3M to bring machine learning to preventive care

CareSkore is combining clinical, socio-economic, demographic, and behavioral data to paint a holistic picture of patients that doctors and insurance companies can use to provide better preventative care. Storm ventures, Cota Capital, Rising Tide Fund and Liquid 2 Ventures are rallying behind the Y Combinator graduate with today’s $4.5 million seed round. Patients receive personalized text messages or phone calls gently nudging them to take action if a new risk factor emerges. CareSkore offers disease specific templates for conditions like COPD and diabetes that can make care recommendations.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 11,2016

DarioHealth Reports Second Quarter 2016 Results

DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today reported financial and operational results for the three and six month period ended June 30, 2016. For the second quarter ended June 30, 2016, revenues were $669,000, a 282% increase from $175,000 for the quarter ended June 30, 2015 and an 18% increase when compared to $568,000 in the first quarter of 2016.

View Analyst & Ambassador Comments
Go to original news
Aug 15,2016

New Charitable Foundation Launched to Award Grants to Diabetes Advocacy Organizations

Today, employees with a drive and enthusiasm to do more beyond their jobs to help the diabetes community announce the formation of the Dexcom One Step Ahead Foundation: A Dexcom Employees Foundation, a nonprofit organization separate from Dexcom, Inc. Dexcom employee contributions and fundraising efforts will support grants of $10,000 to $50,000 to advance the missions and purposes of tax-exempt organizations that provide services and programs to people living with diabetes and their caregivers.

View Analyst & Ambassador Comments
Go to original news
Aug 15,2016

BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin® R U-500 Insulin

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its new syringe for patients using Humulin R U-500 insulin vials. Humulin R U-500 insulin is indicated for patients with diabetes requiring more than 200 units of insulin per day.

REGULATORY FDA
View Analyst & Ambassador Comments
Go to original news
Aug 16,2016

One Drop Expands Diabetes Health and Behavioral Informatics Team With Addition of Chandra Osborn PhD, MPH

One Drop is transforming diabetes self-care by focusing on digital solutions that promote health behaviors through empowerment, mindfulness and motivation. One Drop today announced the hiring of Chandra Osborn PhD, MPH as Vice President of Health and Behavioral Informatics. In her new role, Osborn will expand on the company's efforts to drive data-focused self-care solutions into the healthcare marketplace.

View Analyst & Ambassador Comments
Go to original news
Aug 24,2016

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences: Baird 2016 Healthcare Conference in New York, NY. The presentation will take place on Wednesday, September 7, 2016 at 2:00PM Eastern Time (11:00AM Pacific Time), and 2016 Morgan Stanley Global Healthcare Conference in New York, NY. The presentation will take place on Tuesday, September 13, 2016 at 5:15PM Eastern Time (2:15PM Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 24,2016

1Drop flies to China as part of Swiss National Start-up Team for Venture Leaders

1Drop has been carefully selected among more than 60 high profile applications to participate in Venture Leaders China in October and November 2016. The intense ten-day business development trip will explore Beijing, Tianjin, Shanghai, Shenzhen and Hong Kong.

View Analyst & Ambassador Comments
Go to original news
Aug 26,2016

Brighter announced its half-yearly 2016 report

The company's operating income in the period reached to SEK 12,700 thousand, compared to SEK 5,507 thousand in the same period of the previous year.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES